Summary
DNA amplification, RNA overexpression and p185 protein expression of the c-erbB2 oncogene were investigated in 109 cases of breast cancer with the aim of evaluating any correlation between the different methods. A correlation between Southern blotting and immunohistochemical analysis of paraffin-embedded material was found. Thus, amplification of the c-erbB2 oncogene leads to overexpression of the p185 protein. By contrast, no statistical correlation could be shown between RNA overexpression, measured by Northern blotting, and immunohistochemical p185 membrane stainings. It is of special interest that most of the cases that are positive for Northern blotting and negative for immunochemistry are negative for Southern blotting as well. Contradictory findings between RNA overexpression and lack of immunohistochemical staining of p185 give rise to the assumption that a defective protein is encoded, which cannot be incorporated into the substructures of the tumour cell membrane. When screening for point mutations in the transmembrane domain of the c-erbB2 oncogene, no point mutation could be detected, either by using the endonucleaseFokI, which cuts at position 2012 (the point mutation in theneu gene of the rat), or by direct sequencing.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- PCR:
-
polymerase chain reaction
References
Akiyama T, Sudo CH, Ogawara H, Toyoshima K, Yamamoto T (1986) The product of the human c-erbB2 gene: a 185 kilodalton glycoprotein with tyrosine kinase activity. Science 232:1644–1646
Bargmann CI, Hung MC, Weinberg RA (1986) Multiple independent activations of the oncogene by a point mutation altering the transmembrane domain of p185. Cell 45:649–657
Blair DG, Oskarsson MK, Seth A, Dunn KJ, Dean M, Zweig M, Tainsky MA, Vande Woude DF (1986) Analysis of the transforming potential of the human homolog ofmos. Cell 6:785–794
Borg A, Baldetorp B, Fernö M, Killander D, Olsson H, Sigurdsson H (1991) ER BB2 amplification in breast cancer, with a high rate of proliferation. Oncogene 6:137–143
Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294–5299
Corell B, Zoll B (1988a) Comparison between the allelic frequency distribution of the Ha-ras 1 locus in normal individuals and patients with lymphoma, breast, and ovarian cancer. Hum Genet 79:255–259
Corell B, Zoll B (1988b) Evidence against a tumour-specificEcoRI RFLP of the c-mos locus. FEBS Lett 230:81–84
Coussens L, Yang-Feng TL, Liao YC, Chen E, Gray A, McGrath J, Seeburg PH, Libermann TA, Schlessinger J, Francke U, Levison A, Ullrich A (1985) Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location withneu oncogene. Science 230:1132–1139
De Potter CR, Beghin C, Makar AP, Vandekerckhove D, Roels HUJ (1990) Theneu-oncogene protein as a predictive factor for haematogenous metastases in breast cancer patients. Int J Cancer 45:55–58
Fukushige SI, Matsubara KI, Yoshida M, Sasaki M, Suzuki T, Semba K, Toyoshima K, Yamamoto T (1986) Localisation of a novel v-erbB-related gene c-erbB2 on human chromosome 17 and its amplification in a gastric cancer cell line. Mol Cell Biol 6:955–958
Hanauer A, Levin M, Heilig R, Daegelen D, Kahn A, Mandel JL (1983) Isolation and characterization of cDNA clones for human skeletal muscle α-actin. Nucleic Acid Res 11:3503–3516
Hooberman A, Carrino JJ, Leibowitz D, Rowley Jo, Le Beau MM, Arlin ZA, Westbrook CA (1989) Unexpected heterogeneity of BCR-ABL fusion mRNA detected by polymerase chain reaction in Philadelphia chromosome positive acute lymphoplastic leukemia. Proc Natl Acad Sci USA 86:4259–4263
Kraus MH, Popescu NC, Ambaugh SC, King CR (1987) Overexpression of the EGF receptor-related proto-oncogeneerbB-2 in human mammary tumor cell lines by different molecular mechanisms.Embo J 6:605–610
Maniatis T, Fritsch EF, Sambrook J (1982) Molecular cloning. Cold Spring Harbor Press, Cold Spring Harbor
Marx D, Schauer A, Reiche C, May A, Ummenhofer L, Reles A, Rauschecker H, Sauer R, Schumacher M (1990) C-erbB2 expression in correlation to other biological parameters of breast cancer. J Cancer Res Clin Oncol 116:15–20
Ostertag W, Stocking C, Johnson GR, Kluge N, Kollek R, Franz T, Hess N (1987) Transforming genes and target cells of murine spleen focus-forming viruses. Adv Cancer Res 48:193–355
Saiki RK (1989) The design and optimization of the PCR. In: Ehrlich HA (ed) PCR technology. M Stockton press, New York, pp 7–16
Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci USA 80:4679–4683
Schechter AL, Hung MC, Vaidyanathan L, Weinberg RA, Yang-Feng TL, Francke U, Ullrich A, Coussens L (1985) Theneu gene: anerbb-homologous gene distinct from and unlinked to the gene encoding the EGF receptor. Science 230:976–978
Schöler HR, Hatzopoulos AK, Balling R, Suzuki N, Gruss P (1989) A family of octamer-specific proteins present during mouse embryogenesis: evidence for germline-specific expression of an Oct factor. EMBO J 8:2543–2550
Slamon DJ, Clark GM, Wong SG, Levin WL, Ullrich A, McGuire WL (1987) Correlation of relapse and survival with amplification of theher-2/neu oncogene. Science 235:177–182
Southern EM (1975) Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98:503–517
Vijver MJ van de, Bersselaar R van de, Devilee P, Cornelisse C, Peterse JL, Nusse R (1987) Amplification of theneu (c-erbB-2) oncogene in human mammary tumors is relatively frequent and often accompanied by amplification of the linked c-erbA oncogene. Mol Cell Biol 7:2019–2023
Vijver MJ van de, Peterse JL, Mooi WJ, Wisman P, Lomans J, Dalesio O, Nusse R (1988) Neu-protein overexpression in breast cancer: association with comedo-type, ductal carcinoma in situ and limited prognostic value in stage II breast cancer. N Engl J Med 19:1239–1245
Yamamoto T, Ikawa S, Akiyama T, Semba K, Nomura N, Miyajima N, Saito T, Toyoshima K (1986) Similarity of protein encoded by the human c-erbB-2 gene to epidermal groth factor receptor. Nature 319:230–234
Zeilinger R, Kury F, Czerwenka EK, Sliutz G, Knogler W, Huber J, Zielinsky C, Reiner G, Jakesz R, Staffen A, Reiner A, Wrba F, Spona J (1989) Her-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancer. Oncogene 4:109–114
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zoll, B., Kynast, B., Corell, B. et al. Alterations of the c-erbB2 gene in human breast cancer. J Cancer Res Clin Oncol 118, 468–473 (1992). https://doi.org/10.1007/BF01629432
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01629432